midpage
Sign in to see your projects.
899 F. Supp. 2d 1188
W.D. Okla.
2012
Read the full case

Background

  • Plaintiff owns U.S. Patent No. 6,083,213 covering a left coronary angioplasty using a guiding catheter via femoral approach.
  • Claims 1–2 describe a catheter method that engages the aorta’s inner wall with a 1.5 cm length when positioned in the left ostium.
  • Defendants sold and marketed Medtronic EBU Guiding Catheters alleged to infringe the patent.
  • Jury trial (Jan 2012) found infringement by defendants, with inducement and contributory infringement, willfulness, and a royalty of $9,900,000.
  • Court granted partial summary judgment on validity; issues of obviousness and prior public use reserved for trial, but Defendants withdrew validity defenses during trial.
  • Post-trial motions: JMOL denied on infringement but granted on willfulness; prejudgment interest and enhanced damages/fees addressed in final rulings.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Direct infringement proven? Voda. Medtronic challenged validity/undermined infringement. No JMOL; infringement supported by trial evidence.
Inducement and contributory infringement proven? Inducement shown by defendants’ publications and training. No clear intent or no substantial noninfringing use. Sustained contributory infringement; inducement by intent found.
Willfulness proven? Defendants acted with knowledge or obviousness of infringement. Defenses not objectively unreasonable. Willfulness not proven; Seagate objective prong not satisfied; JMOL reversed for willfulness.
Damages support for 14.3% royalty? Dr. Wu supported higher rate; damages within credible range. Rate too high; expert testimony inconsistent. Royalty within evidentiary bounds; not undue.
Prejudgment interest, enhanced damages, attorney’s fees? Not undue delay; prejudgment interest appropriate. Objectively unreasonable conduct warranted enhanced damages/fees. Prejudgment interest awarded; enhanced damages and attorney’s fees denied.

Key Cases Cited

  • Lucent Technologies, Inc. v. Gateway, Inc., 580 F.3d 1301 (Fed.Cir. 2009) (infringement requires practicing all steps of the claimed method)
  • Metabolite Laboratories, Inc. v. Lab. Corp. of Am. Holdings, 370 F.3d 1354 (Fed.Cir. 2004) (intent to induce infringement shown by circumstantial evidence)
  • In re Seagate Tech., LLC, 497 F.3d 1360 (Fed.Cir. 2007) (two-prong test for willful infringement; objective prong first)
  • Bard Peripheral Vascular, Inc. v. Gore & Assocs., 682 F.3d 1003 (Fed.Cir. 2012) (objective prong of Seagate treated as question of law with mixed questions of fact)
  • Gasperini v. Center for Humanities, Inc., 518 U.S. 415 (U.S. 1996) (standard for granting a new trial; abuse of discretion if verdict against weight of the evidence)
  • Jurgens, 80 F.3d 1566, 80 F.3d 1566 (Fed.Cir. 1996) (enhanced damages and attorney’s fees analysis; two-step Read Corp. factors)
  • Read Corp. v. Portee, Inc., 970 F.2d 816 (Fed.Cir. 1992) (factors for evaluating enhanced damages under §284)
  • Professional Real Estate Investors, Inc. v. Columbia Pictures Indus., Inc., 508 U.S. 49 (U.S. 1993) (rejections of objectively unreasonable defenses in willfulness analysis)
Read the full case

Case Details

Case Name: Voda v. Medtronic Inc.
Court Name: District Court, W.D. Oklahoma
Date Published: Sep 27, 2012
Citations: 899 F. Supp. 2d 1188; 2012 WL 4470644; 2012 U.S. Dist. LEXIS 139324; Case No. CIV-09-95-L
Docket Number: Case No. CIV-09-95-L
Court Abbreviation: W.D. Okla.
Log In